1. Clinical illness with viable SARS-CoV-2 virus presenting 72 days after infection in an immunocompromised patient.
- Author
-
Salvaris R., Pierce A.B., Druce J.D., Catton M., Chong B., Sherry N.L., Graham M., Chen M., Eise N., Stuart R.L., Korman T.M., Looker C., Crouch S., McQuilten Z., Lee J.Y.H., Hughes C.M., Gregory G.P., Salvaris R., Pierce A.B., Druce J.D., Catton M., Chong B., Sherry N.L., Graham M., Chen M., Eise N., Stuart R.L., Korman T.M., Looker C., Crouch S., McQuilten Z., Lee J.Y.H., Hughes C.M., and Gregory G.P.
- Abstract
We present a case of late symptom onset of COVID-19 infection 72 days after initial diagnosis in an immunocompromised 53-year-old man. SARS-CoV-2 was cultured from his sputum sample at this time, and genomic sequencing suggested reinfection was unlikely. After receipt of convalescent plasma, SARS-CoV-2 became undetectable by PCR 111 days after diagnosis, although SARS-CoV-2 antibodies remained not detectable. This case posed difficult public health management issues in a low prevalence COVID-19 setting as the person required extended home isolation given his prolonged SARS-CoV-2 PCR detection.Copyright © 2021 by The Society for Healthcare Epidemiology of America. All rights reserved.
- Published
- 2021